Expected Revenue Growth:
The liquid handling system market is expected to reach USD 3.74 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 7.2%.
Major Growth Boosting Factors:
Factors like the rapid growth of biotechnology and pharmaceutical industries, growing demand for high-throughput screening (HTS), rising focus on data precision and accuracy, and technological advancements are driving the growth of this market.
The liquid handling system market is consolidated in nature due to the presence of a large number of players. The key players in the market are Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Tecan Group Ltd. (Switzerland), Gardner Denver Medical (Germany), Mettler-Toledo International Inc. (U.S.), Hamilton Company (U.S.), PerkinElmer, Inc. (U.S.), Sartorius AG (Germany), Corning Incorporated (U.S.), Gilson, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Qiagen N.V. (Germany), Lonza Group Ltd (Switzerland), Brooks Automation, Inc. (U.S.), Integra Holding AG (Switzerland), Endress+Hauser AG (Switzerland), Labcyte Inc. (U.S.), BioTek Instruments, Inc. (U.S.), TTP Labtech Ltd (U.K.), Metrohm AG (Switzerland), BRAND GMBH + CO KG (Germany), Tomtec, Inc. (U.S.), Hudson Robotics, Inc. (U.S.), and Orochem Technologies Inc. (U.S.).
Download PDF Brochure@
Major Growth Strategies Adopted by Them:
The key strategy followed by most companies in the liquid handling systems market are product launches. This strategy accounted for the largest share of the overall growth strategies mapped from 2015 to 2017. Some of the leading players that adopted this strategy include Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Tecan Group Ltd. (Switzerland), Hamilton Company (U.S.), and Gilson, Inc. (U.S.).
Danaher Corporation (U.S.) accounted for the largest share of the liquid handling system market in 2016. The company operates in the liquid handling systems market through its subsidiary, Beckman Coulter, Inc. This subsidiary offers advanced automated liquid handling workstations along with the required software and consumables.
The company launched an innovative liquid handling system in 2017 and enhanced an existing product in 2015. The company has a global presence and is financially strong. It adopted partnerships as its major strategy to maintain its leading position in the liquid handling systems market. For instance, in 2015, Danaher Corporation partnered with Illumina, Inc. (U.S.), a manufacturer of life science instruments. This partnership improved automation for Next-generation Sequencing (NGS).
Thermo Fisher Scientific Inc. (U.S.) accounted for the second-largest market share of the liquid handling systems market in 2016. The company caters to the liquid handling systems market through its Laboratory Products and Services segment. The end users that the company caters to are pharmaceutical and biotechnology companies, hospitals and clinical diagnostic laboratories, universities, research institutions, government agencies, and environmental & process control industries. The company offers a broad range of products covering all segments in liquid handling systems.
The company launched innovative products for liquid handling over the last three years in all categories, namely, electronic systems, automated systems, and manual systems. The company used product innovation as the main strategy to maintain its competitive position in the market. For instance, the company presented the Thermo Scientific My Pipette Creator at the annual meeting of the American Association for Cancer Research in 2017. This cloud-based application is designed with the aim of enabling centralized programming of connected pipettes and sharing pipetting protocols through the network.
North America expected to account for the major share of the market in 2017
Based on region, the liquid handling system market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to dominate the liquid handling systems market in 2017 on account of growth in the biotechnology and pharmaceutical industries, rising prevalence of chronic diseases, and higher investments in genomics and proteomics research in the region.
Request Sample Pages@
Target Audience for this Report:
# Genomics and proteomics associations
# Drug discovery and development research centers
# Hospitals and diagnostic laboratories
# Research & consulting firms
# Distributors of liquid handling products
# Contract manufacturers of protein liquid handling systems and consumables
# Research institutes and clinical research organizations (CROs)
# Venture capitalists
# Government associations